Table IV.
P300 peak amplitudes [μV] of visual ERP
| Total | Female | Male | P a | |
|---|---|---|---|---|
| Fzneutral target | 2.29 ± 2.08 | 2.62 ± 2.03 | 1.96 ± 2.12 | 0.195 |
| Czneutral target | 4.58 ± 2.37 | 4.28 ± 2.43 | 4.89 ± 2.33 | 0.239 |
| Pzneutral target | 4.91 ± 2.03 | 4.57 ± 2.29 | 5.26 ± 1.73 | 0.153 |
| Fzcongruent target | 2.43 ± 2.14 | 2.61 ± 2.02 | 2.24 ± 2.28 | 0.329 |
| Czcongruent target | 4.44 ± 2.50 | 4.04 ± 2.78 | 4.83 ± 2.18 | 0.138 |
| Pzcongruent target | 4.56 ± 2.00 | 4.33 ± 2.18 | 4.79 ± 1.83 | 0.278 |
| Fzincongruent target | 2.73 ± 2.21 | 2.99 ± 2.35 | 2.48 ± 2.09 | 0.289 |
| Czincongruent target | 4.61 ± 2.50 | 4.17 ± 2.49 | 5.04 ± 2.49 | 0.267 |
| Pzincongruent target | 3.67 ± 1.89 | 3.39 ± 2.06 | 3.95 ± 1.70 | 0.177 |
a
Post hoc ANOVAS.
Abbreviations: Fz, frontal midline electrode; Cz, central midline electrode; Pz, parietal midline electrode.